ReP USP - Resultado da busca

Artigo de periodico
Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews (2024)
Visacri, Marilia Berlofa ; Ribeiro, Mayra Carvalho; Komoda, Denis Satoshi; Duarte, Bruno Kosa Lino; Corrêa, Carlos Roberto Silveira; Maia, Flávia de Oliveira Motta ; Alves, Daniela Fernanda dos Santos
Source: Value in Health Regional Issues. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VISACRI, Marilia Berlofa et al. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, v. 43, p. 1-10 art. 100998, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vhri.2024.100998. Acesso em: 08 set. 2024.
APA
Visacri, M. B., Ribeiro, M. C., Komoda, D. S., Duarte, B. K. L., Corrêa, C. R. S., Maia, F. de O. M., & Alves, D. F. dos S. (2024). Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, 43, 1-10 art. 100998. doi:10.1016/j.vhri.2024.100998
NLM
Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 set. 08 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
Vancouver
Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 set. 08 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
Artigo de periodico
A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma (2024)
Park, Ji Won; Pereira, Taynna Tatiane; Rotta, Inajara ; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Visacri, Marilia Berlofa
Source: International Journal of Clinical Pharmacy. Unidade: FCF
Subjects: FARMACÊUTICOS, MIELOMA MÚLTIPLO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARK, Ji Won et al. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11096-024-01787-x. Acesso em: 08 set. 2024.
APA
Park, J. W., Pereira, T. T., Rotta, I., Lima, T. de M., Aguiar, P. M., & Visacri, M. B. (2024). A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy. doi:10.1007/s11096-024-01787-x
NLM
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 set. 08 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
Vancouver
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 set. 08 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
Trabalho de evento-resumo
O papel do farmacêutico clínico no cuidado do paciente com mieloma múltiplo: uma revisão de escopo (2023)
Park, Ji Won; Pereira, Taynna Tatiane; Rotta, Inajara ; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Visacri, Marilia Berlofa
Source: Anais. Conference titles: Congresso Farmacêutico de São Paulo. Unidade: FCF
Subjects: FARMACÊUTICOS, MIELOMA MÚLTIPLO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARK, Ji Won et al. O papel do farmacêutico clínico no cuidado do paciente com mieloma múltiplo: uma revisão de escopo. 2023, Anais.. São Paulo: Conselho Regional de Farmácia do Estado de São Paulo/CRFSP, 2023. Disponível em: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf. Acesso em: 08 set. 2024.
APA
Park, J. W., Pereira, T. T., Rotta, I., Lima, T. de M., Aguiar, P. M., & Visacri, M. B. (2023). O papel do farmacêutico clínico no cuidado do paciente com mieloma múltiplo: uma revisão de escopo. In Anais. São Paulo: Conselho Regional de Farmácia do Estado de São Paulo/CRFSP. Recuperado de https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
NLM
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. O papel do farmacêutico clínico no cuidado do paciente com mieloma múltiplo: uma revisão de escopo [Internet]. Anais. 2023 ;[citado 2024 set. 08 ] Available from: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
Vancouver
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. O papel do farmacêutico clínico no cuidado do paciente com mieloma múltiplo: uma revisão de escopo [Internet]. Anais. 2023 ;[citado 2024 set. 08 ] Available from: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
Artigo de periodico
Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses (2017)
Aguiar, Patrícia Melo ; Lima, Tácio de Mendonça; Colleoni, Gisele Wally Braga; Storpirtis, Silvia
Source: Critical Reviews in Oncology Hematology. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo et al. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, v. 113, p. 195-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2017.03.014. Acesso em: 08 set. 2024.
APA
Aguiar, P. M., Lima, T. de M., Colleoni, G. W. B., & Storpirtis, S. (2017). Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, 113, 195-212. doi:10.1016/j.critrevonc.2017.03.014
NLM
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 set. 08 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
Vancouver
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 set. 08 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
Artigo de periodico
Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? (2016)
Aguiar, Patrícia Melo ; Lima, T M; Storpirtis, Silvia
Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Patrícia Melo e LIMA, T M e STORPIRTIS, Silvia. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?. Journal of Clinical Pharmacy and Therapeutics, v. 41, n. 2, p. 189-197, 2016Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12384. Acesso em: 08 set. 2024.
APA
Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2016). Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? Journal of Clinical Pharmacy and Therapeutics, 41( 2), 189-197. doi:10.1111/jcpt.12384
NLM
Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 set. 08 ] Available from: https://doi.org/10.1111/jcpt.12384
Vancouver
Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 set. 08 ] Available from: https://doi.org/10.1111/jcpt.12384
Artigo de periodico
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease (2004)
Hungria, Vania Tietsche de Moraes; Latrilha, Maria C.; Rodrigues, Debora G.; Bydlowski, Sérgio Paulo; Chiattone, Carlos Sérgio; Maranhão, Raul Cavalcante
Source: Cancer Chemotherapy and Pharmacology. Unidades: FCF, FM
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), MIELOMA MÚLTIPLO, QUIMIOTERAPIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUNGRIA, Vania Tietsche de Moraes et al. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, v. 53, n. 1, p. 51-60, 2004Tradução . . Disponível em: https://doi.org/10.1007/bf02665353. Acesso em: 08 set. 2024.
APA
Hungria, V. T. de M., Latrilha, M. C., Rodrigues, D. G., Bydlowski, S. P., Chiattone, C. S., & Maranhão, R. C. (2004). Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, 53( 1), 51-60. doi:10.1007/bf02665353
NLM
Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease [Internet]. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.[citado 2024 set. 08 ] Available from: https://doi.org/10.1007/bf02665353
Vancouver
Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease [Internet]. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.[citado 2024 set. 08 ] Available from: https://doi.org/10.1007/bf02665353

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Non normalized affiliation